Dementia/Alzheimer's Clinical Trials 3/9/17

Posted at 12:27 PM, Mar 09, 2017
and last updated 2017-03-09 12:27:30-05

Dr. Targum consults widely to the pharmaceutical industry in the areas of psychiatric disorders, clinical trial methodologies, protocol design, study surveillance strategies, study analysis, and the progression of new drug candidates from concept to approval to launch. 

Dr. Targum is currently the Scientific Director at Bracket Global where he is focused on optimizing signal detection for clinical trials across the CNS spectrum.  Dr. Targum has been Chief Medical Officer at Brain Cells Inc., Methylation Sciences Inc., and Functional Neuromodulation Inc. He is currently the Chief Medical Officer at Resilience Therapeutics investigating post-traumatic stress disorder and Chief Medical Advisor at Neurim Pharmaceuticals where he assists with the execution of a clinical trial for Alzheimer’s disease.